实用药物与临床
實用藥物與臨床
실용약물여림상
PRACTICAL PHARMACY AND CLINICAL REMEDIES
2014年
5期
572-575
,共4页
帕罗西汀%多虑平%氯唑沙宗%焦虑%抑郁%紧张型头痛
帕囉西汀%多慮平%氯唑沙宗%焦慮%抑鬱%緊張型頭痛
파라서정%다필평%록서사종%초필%억욱%긴장형두통
Paroxetine%Doxepin%Chlorzoxazone%Anxiety%Depression%Tension-type headache
目的:比较帕罗西汀和多虑平联合氯唑沙宗治疗伴有焦虑抑郁情绪的紧张型头痛的临床疗效及安全性。方法选择在我科门诊治疗伴有焦虑抑郁情绪的紧张型头痛患者56例为研究对象,采用随机数字表法分为帕罗西汀组和多虑平组,每组28例,帕罗西汀组在常规服用氯唑沙宗的基础上加服帕罗西汀治疗,多虑平组加服多虑平治疗,另外回顾以往常规应用氯唑沙宗治疗的伴有焦虑抑郁情绪的紧张型头痛患者30例的临床资料,并作为对照组。分别对治疗12周后三组患者头痛、焦虑抑郁情绪改善情况及药物不良反应发生情况进行评价,并进行对比分析。结果所有患者均顺利完成12周的治疗,治疗后帕罗西汀组显效率和总有效率均明显高于对照组,差异均有统计学意义(P<0.05或P<0.01);帕罗西汀组患者总有效率略高于多虑平组,但差异无统计学意义(P>0.05),而帕罗西汀组显效率明显高于多虑平组,差异有统计学意义(P<0.05);多虑平组显效率与对照组相当,总有效率高于对照组,但差异无统计学意义( P>0.05)。帕罗西汀组和多虑平组患者HAMA评分和HAMD评分均较治疗前明显改善(P<0.01),且改善程度明显优于对照组(P<0.05);与多虑平组相比,帕罗西汀组HAMA和HAMD评分改善更为明显,差异均有统计学意义( P<0.05)。帕罗西汀组和对照组不良反应发生率和不良反应严重程度评分均明显低于多虑平组( P<0.05或P<0.01);而帕罗西汀组和对照组间差异无统计学意义(P>0.05)。结论帕罗西汀联合氯唑沙宗治疗伴有焦虑抑郁的紧张型头痛的临床疗效满意,不良反应少,且较轻微,值得临床推广应用。
目的:比較帕囉西汀和多慮平聯閤氯唑沙宗治療伴有焦慮抑鬱情緒的緊張型頭痛的臨床療效及安全性。方法選擇在我科門診治療伴有焦慮抑鬱情緒的緊張型頭痛患者56例為研究對象,採用隨機數字錶法分為帕囉西汀組和多慮平組,每組28例,帕囉西汀組在常規服用氯唑沙宗的基礎上加服帕囉西汀治療,多慮平組加服多慮平治療,另外迴顧以往常規應用氯唑沙宗治療的伴有焦慮抑鬱情緒的緊張型頭痛患者30例的臨床資料,併作為對照組。分彆對治療12週後三組患者頭痛、焦慮抑鬱情緒改善情況及藥物不良反應髮生情況進行評價,併進行對比分析。結果所有患者均順利完成12週的治療,治療後帕囉西汀組顯效率和總有效率均明顯高于對照組,差異均有統計學意義(P<0.05或P<0.01);帕囉西汀組患者總有效率略高于多慮平組,但差異無統計學意義(P>0.05),而帕囉西汀組顯效率明顯高于多慮平組,差異有統計學意義(P<0.05);多慮平組顯效率與對照組相噹,總有效率高于對照組,但差異無統計學意義( P>0.05)。帕囉西汀組和多慮平組患者HAMA評分和HAMD評分均較治療前明顯改善(P<0.01),且改善程度明顯優于對照組(P<0.05);與多慮平組相比,帕囉西汀組HAMA和HAMD評分改善更為明顯,差異均有統計學意義( P<0.05)。帕囉西汀組和對照組不良反應髮生率和不良反應嚴重程度評分均明顯低于多慮平組( P<0.05或P<0.01);而帕囉西汀組和對照組間差異無統計學意義(P>0.05)。結論帕囉西汀聯閤氯唑沙宗治療伴有焦慮抑鬱的緊張型頭痛的臨床療效滿意,不良反應少,且較輕微,值得臨床推廣應用。
목적:비교파라서정화다필평연합록서사종치료반유초필억욱정서적긴장형두통적림상료효급안전성。방법선택재아과문진치료반유초필억욱정서적긴장형두통환자56례위연구대상,채용수궤수자표법분위파라서정조화다필평조,매조28례,파라서정조재상규복용록서사종적기출상가복파라서정치료,다필평조가복다필평치료,령외회고이왕상규응용록서사종치료적반유초필억욱정서적긴장형두통환자30례적림상자료,병작위대조조。분별대치료12주후삼조환자두통、초필억욱정서개선정황급약물불량반응발생정황진행평개,병진행대비분석。결과소유환자균순리완성12주적치료,치료후파라서정조현효솔화총유효솔균명현고우대조조,차이균유통계학의의(P<0.05혹P<0.01);파라서정조환자총유효솔략고우다필평조,단차이무통계학의의(P>0.05),이파라서정조현효솔명현고우다필평조,차이유통계학의의(P<0.05);다필평조현효솔여대조조상당,총유효솔고우대조조,단차이무통계학의의( P>0.05)。파라서정조화다필평조환자HAMA평분화HAMD평분균교치료전명현개선(P<0.01),차개선정도명현우우대조조(P<0.05);여다필평조상비,파라서정조HAMA화HAMD평분개선경위명현,차이균유통계학의의( P<0.05)。파라서정조화대조조불량반응발생솔화불량반응엄중정도평분균명현저우다필평조( P<0.05혹P<0.01);이파라서정조화대조조간차이무통계학의의(P>0.05)。결론파라서정연합록서사종치료반유초필억욱적긴장형두통적림상료효만의,불량반응소,차교경미,치득림상추엄응용。
Objective To compare the clinical efficacy and safety of tension-type headache with anxiety de-pression treating with paroxetine and doxepin combined with chlorzoxazone. Methods To choose tension headache pa-tients with anxiety depression as the research object,using the random number table method,the patients were divided into paroxetine group and doxepin group,paroxetine group took chlorzoxazone treatment plus paroxetine on the basis of routine therapy,doxepin group plus doxepin therapy. The patients treating with chlorzoxazone as a control group,at 12 weeks after treatment,evaluated the condition of patients with headache,anxiety,depression mood and drug side effects of the three groups,and gave comparative analysis. Results All patients successfully completed 12 weeks treatment, after treatment,the total effective rate and significant efficiency of paroxetine group were obviously higher than that of control group ( P <0. 05 or P <0. 01 );the total effective rate of paroxetine group was slightly higher than that of doxepin group,but there was no significant difference (P >0. 05),but the significant efficiency of paroxetine group was obviously higher than that of doxepin group,the difference was significant (P<0. 05);the significant efficiency of doxepin group and control group had no significant difference,the total effective rate was slightly higher than that of control group,but there was no significant difference between the two groups (P>0. 05). HAMA and HAMD scores of paroxetine group and doxepin group obviously improved than that of prior treatment (P<0. 01),and the improved de-gree was better than the control group (P<0. 05);Compared with doxepin group,HAMA and HAMD scores improve-ment of paroxetine group was more apparent,the difference was significant (P<0. 05). The incidence of adverse e-vents of paroxetine group and control group were obviously lower than that of doxepin group (P<0. 05 or P<0. 01), and the difference of paroxetine group and control group had no significant difference ( P>0. 05 ) . Conclusion The clinical efficacy of tension-type headache with anxiety depression treating with paroxetine combined chlorzoxazone is obvious,the adverse events are less and slight,and shows good security,it is worth of popularization and application.